VALBIOTIS (EPA:ALVAL)

BRIEF

published on 01/14/2025 at 17:49, 1 year ago

Valbiotis Announces Success in HEART II Study on Lipidrive

Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
PRESS RELEASE

published on 01/14/2025 at 17:44, 1 year ago

VALBIOTIS SA: Valbiotis announces the major success of the phase II/III HEART II clinical study on LIPIDRIVE
Valbiotis announces success of phase II/III HEART II study on LIPIDRIVE, proving efficacy in reducing LDL cholesterol for mild to moderate hypercholesterolemia. Study validates safety & compliance of Lipidrive

Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol
BRIEF

published on 01/08/2025 at 12:02, 1 year ago

Half-yearly report on the Valbiotis liquidity contract

Liquidity Contract PORTZAMPARC Valbiotis Sotck Exchange Stock Market Transactions
BRIEF

published on 12/17/2024 at 11:19, 1 year 1 month ago

VALBIOTIS: Monthly Information on Voting Rights and Shares

Euronext Growth Paris Voting Rights Actions Valbiotis Threshold Crossing
BRIEF

published on 12/17/2024 at 11:19, 1 year 1 month ago

VALBIOTIS: Information on Voting Rights and Shares

Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF

published on 11/28/2024 at 17:45, 1 year 2 months ago

Valbiotis and Asetys form a strategic partnership

Partnership Prevention Educational Workshops Food Supplements Natural Health
PRESS RELEASE

published on 11/28/2024 at 17:40, 1 year 2 months ago

VALBIOTIS SA: Valbiotis® announces a strategic partnership with Asetys, a complementary health insurance provider and recognized specialist in natural solutions and prevention
Valbiotis® partners with Asetys, a health insurance provider specialized in natural solutions and prevention, to democratize access to natural therapies for better health

Valbiotis Preventive Healthcare Health Insurance Asetys Natural Therapies
PRESS RELEASE

published on 11/28/2024 at 17:40, 1 year 2 months ago

VALBIOTIS SA: Valbiotis® announces a strategic partnership with Asetys, a complementary health insurance provider and recognized specialist in natural solutions and prevention
Valbiotis® announces a strategic partnership with Asetys, a complementary health insurance provider, to democratize access to natural therapies and preventive healthcare solutions. The collaboration will focus on raising awareness and providing educational workshops

Valbiotis Preventive Healthcare Health Insurance Asetys Natural Therapies
BRIEF

published on 11/20/2024 at 11:55, 1 year 2 months ago

VALBIOTIS SA: Monthly update on the capital structure

Share Capital Voting Rights Euronext Growth Valbiotis Financial Regulations
BRIEF

published on 11/20/2024 at 11:54, 1 year 2 months ago

VALBIOTIS SA: Update on voting rights and shares

Voting Rights Actions Euronext Growth Valbiotis Crossing Thresholds

Published on 01/30/2026 at 08:00, 18 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 6 hours 3 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 8 hours 18 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 9 hours 18 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 13 hours 33 minutes ago

Silver Spruce Appoints Vice-President of Exploration

View all ACCESSWIRE

Published on 01/30/2026 at 08:00, 18 minutes ago

Ørsted to present its annual report for 2025 on February 6
Published on 01/30/2026 at 08:00, 18 minutes ago

Transaction in Own Shares
Published on 01/30/2026 at 08:00, 18 minutes ago

Aquis Stock Exchange: Admission to trading
Published on 01/30/2026 at 07:29, 49 minutes ago

Consolidated profit (excluding Russia) above 1.4 billion euros
Published on 01/30/2026 at 07:00, 1 hour 18 minutes ago

Unbroken record series with high revenue momentum for cloud and subscriptions – 20th record year in a row for revenue and earnings

View all EQS

Published on 01/30/2026 at 08:00, 18 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 14 hours 18 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 14 hours 33 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 14 hours 33 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 14 hours 38 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News